During the week ending May 13, 2016, the U.S. House of Representatives approved a comprehensive set of 18 bills aimed at curbing the opioid epidemic. The largest of these bills, the Comprehensive Opioid Abuse Reduction Act of 2016 (H.R. 5046), passed by a 413-5 vote in the House on May 12, 2016.  This bill authorizes US $103 million dollars in grant funding for fiscal years 2017 through 2021, and makes the U.S. Department of Justice (DOJ) responsible for administering grants to state, local, and tribal governments to provide a range of opioid abuse services.  These services include developing and expanding existing programs to combat opioid abuse, training first responders in administering opioid overdose reversal medication, and providing dedicated opioid treatment and prevention services for veterans.  In March 2016, the Senate passed a similar measure, titled the Comprehensive Addiction and Recovery Act of 2016 (S. 524), which authorizes the Attorney General to award similar grants.

On April 6, 2016, the Food and Drug Administration (FDA) published the final rule for the sanitary transportation of human and animal food.  The rule aims to prevent food contamination during transportation by requiring covered entities involved in transporting human and animal food to follow recognized best practices for sanitary transportation.  The rule seeks to prevent unsanitary practices such as the failure to properly refrigerate food, the inadequate cleaning of vehicles between loads, and the failure to properly protect food. 

On March 16, 2016, the U.S. Senate voted 48-49 against invoking cloture to cut off a filibuster on the Biotechnology Labeling Solutions Act.  The bill would have established a federal standard of voluntary labeling and preempted any mandatory GMO labeling state laws.  In July 2015, a similar bill called the  Safe and Accurate Food Labeling Act of 2015 successfully passed through the U.S. House of Representatives.[1]  In October 2015, the U.S. Senate Committee on Agriculture, Nutrition & Forestry held a hearing on the mandatory labeling of genetically engineered crops that focused on the House bill.

On February 22, the Centers for Medicare and Medicaid Services (CMS) announced its intention to further enhance CMS’s ability to screen providers and suppliers enrolling or currently enrolled in Medicare for compliance with Medicare enrollment requirements. Specifically, CMS will strengthen existing screening measures by increasing the number of site visits to Medicare enrolled providers and suppliers, enhancing address verification software in CMS’s Provider Enrollment Chain and Ownership System (PECOS), analyzing enrollment data to identify and deactivate certain providers who have not billed Medicare within the last 13 months, and monitoring and identifying potentially invalid addresses contained in initial enrollment applications.

CMS issued a proposed rule on January 28, 2016 that would significantly overhaul benchmark calculations for Medicare Shared Savings Program Accountable Care Organizations (MSSP ACOs), which may increase the long-term attractiveness of the MSSP for high-performing ACOs.